BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 6319446)

  • 1. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
    Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
    Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome.
    Lüdecke DK; Westphal M; Schabet M; Höllt V
    Horm Res; 1980; 13(4-5):259-79. PubMed ID: 6268513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
    Suda T; Tomori N; Tozawa F; Demura H; Shizume K
    J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
    Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
    Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
    Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G
    Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between systemic corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin release in vivo varies as a function of gestational age in the ovine fetus.
    Norman LJ; Challis JR
    Endocrinology; 1987 Mar; 120(3):1052-8. PubMed ID: 3026785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
    Yasuda Y; Yasuda N
    Horm Metab Res; 1986 May; 18(5):313-7. PubMed ID: 3013743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressin.
    Oosterom R; Verleun T; Bruining HA; Hackeng WH; Lamberts SW
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):65-72. PubMed ID: 3020852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies for clinical application of ovine corticotropin-releasing factor].
    Kubo M
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of various corticotropin-releasing factor trains on the release of adrenocorticotropin, beta-endorphin, and beta-lipotropin from perifused ovine pituitary cells.
    Evans MJ; Brett JT; McIntosh RP; McIntosh JE; Roud HK; Livesey JH; Donald RA
    Endocrinology; 1985 Sep; 117(3):893-9. PubMed ID: 2990876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
    Familari M; Smith AI; Smith R; Funder JW
    Neuroendocrinology; 1989 Aug; 50(2):152-7. PubMed ID: 2550836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome.
    van Wijk PA; Rijnberk A; Croughs RJ; Wolfswinkel J; Selman PJ; Mol JA
    Eur J Endocrinol; 1994 Apr; 130(4):410-6. PubMed ID: 8162173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.